Results 61 to 70 of about 141 (84)

Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors. [PDF]

open access: yesNat Commun
Cao J   +14 more
europepmc   +1 more source

Impact of secretin receptor homo-dimerization on natural ligand binding. [PDF]

open access: yesNat Commun
Harikumar KG   +5 more
europepmc   +1 more source

Altered Intracellular Trafficking as a Mechanism for Prolonged Duration of G Protein-Coupled Receptor Activation. [PDF]

open access: yesJ Am Chem Soc
Kim TW   +7 more
europepmc   +1 more source

Cholesterol-dependent dynamic changes in the conformation of the type 1 cholecystokinin receptor affect ligand binding and G protein coupling. [PDF]

open access: yesPLoS Biol
Harikumar KG   +13 more
europepmc   +1 more source

What is the pipeline for future medications for obesity? [PDF]

open access: yesInt J Obes (Lond)
Melson E   +3 more
europepmc   +1 more source

DACRA induces profound weight loss, satiety control, and increased mitochondrial respiratory capacity in adipose tissue

open access: yesInternational Journal of Obesity
Dual amylin and calcitonin receptor agonists (DACRAs) are therapeutic candidates in the treatment of obesity with beneficial effects on weight loss superior to suppression of food intake. Hence, suggesting effects on energy expenditure by possibly targeting mitochondria in metabolically active tissue.Male rats with HFD-induced obesity received a DACRA,
Morten Karsdal   +2 more
exaly   +6 more sources
Some of the next articles are maybe not open access.

Related searches:

KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight

American Journal of Physiology - Endocrinology and Metabolism, 2016
This study aims to elucidate the mechanism behind the potent weight loss induced by dual amylin and calcitonin receptor agonists (DACRA) through comparison of the novel DACRA KBP-088 with the amylinomimetic davalintide with regard to in vitro receptor pharmacology and in vivo efficacy on food intake and body weight. KBP-088 and davalintide were tested
Morten Karsdal   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy